VAXIRNA

Serial Number 85032584
606

Registration Progress

Application Filed
May 7, 2010
Under Examination
Sep 27, 2011
Approved for Publication
Jul 13, 2011
Published for Opposition
Aug 2, 2011
Registered

Basic Information

Serial Number
85032584
Filing Date
May 7, 2010
Published for Opposition
August 2, 2011
Abandonment Date
November 3, 2014
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 3, 2014
Classes
005 042

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
300 Third Street, 3rd Floor
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Ann Lamport Hammitte

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

42 events
Date Code Type Description
Nov 3, 2014 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Nov 3, 2014 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Mar 26, 2014 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Mar 25, 2014 EX5G S SOU EXTENSION 5 GRANTED
Mar 13, 2014 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 13, 2014 EXT5 S SOU EXTENSION 5 FILED
Sep 25, 2013 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Sep 24, 2013 EX4G S SOU EXTENSION 4 GRANTED
Sep 10, 2013 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 10, 2013 EXT4 S SOU EXTENSION 4 FILED
Feb 26, 2013 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Feb 25, 2013 EX3G S SOU EXTENSION 3 GRANTED
Feb 21, 2013 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 21, 2013 EXT3 S SOU EXTENSION 3 FILED
Sep 29, 2012 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Sep 28, 2012 EX2G S SOU EXTENSION 2 GRANTED
Sep 26, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 26, 2012 EXT2 S SOU EXTENSION 2 FILED
Mar 13, 2012 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Mar 12, 2012 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 12, 2012 EX1G S SOU EXTENSION 1 GRANTED
Feb 15, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 15, 2012 EXT1 S SOU EXTENSION 1 FILED
Sep 27, 2011 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Aug 2, 2011 PUBO A PUBLISHED FOR OPPOSITION
Jul 13, 2011 NPUB O NOTICE OF PUBLICATION
Jun 24, 2011 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 22, 2011 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 18, 2011 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 18, 2011 ACEC I AMENDMENT FROM APPLICANT ENTERED
Jun 6, 2011 MAIL I PAPER RECEIVED
Apr 13, 2011 CNRT R NON-FINAL ACTION WRITTEN
Apr 13, 2011 CNRT O NON-FINAL ACTION MAILED
Mar 15, 2011 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 2011 ACEC I AMENDMENT FROM APPLICANT ENTERED
Mar 8, 2011 ALIE A ASSIGNED TO LIE
Feb 28, 2011 MAIL I PAPER RECEIVED
Aug 24, 2010 CNRT R NON-FINAL ACTION WRITTEN
Aug 24, 2010 CNRT F NON-FINAL ACTION MAILED
Aug 19, 2010 DOCK D ASSIGNED TO EXAMINER
May 13, 2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 11, 2010 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
a full line of pharmaceutical preparations, biological preparations, and vaccines for medical purposes
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
scientific research, scientific research in the fields of pharmaceuticals, vaccines and medicine; pharmaceutical, biological and vaccine research and development services; consulting services in the field of researching and development of pharmaceutical preparations, vaccines and biologics
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 042